Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of famotidine on vagal inflammatory reflex in coronary artery disease
IRCT20240927063180N1Phase 3Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of famotidine in coronary arteriosclerosis, sponsored by Baqiyatallah University of Medical Sciences. Started Dec 2024; status: completed.
02
Drugs
famotidine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20240927063180N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240927063180N1.